Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) had its price target reduced by JPMorgan Chase & Co. from $33.00 to $32.00 in a research report released on Monday, Benzinga reports. They currently have a neutral rating on the biopharmaceutical company’s stock. Other analysts have also issued research reports about the stock. SVB Securities decreased their price […]
Agios Pharmaceuticals (NASDAQ:AGIO) Releases Earnings Results, Beats Estimates By $0 09 EPS theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Agios Pharmaceuticals (NASDAQ:AGIO – Get Free Report) posted its quarterly earnings results on Thursday. The biopharmaceutical company reported ($1.51) EPS for the quarter, beating the consensus estimate of ($1.60) by $0.09, Briefing.com reports. Agios Pharmaceuticals had a negative return on equity of 19.77% and a negative net margin of 1,042.56%. The firm had revenue of […]
Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) dropped 4.1% during trading on Thursday . The company traded as low as $27.94 and last traded at $28.00. Approximately 334,693 shares traded hands during mid-day trading, a decline of 34% from the average daily volume of 505,727 shares. The stock had previously closed at $29.19. […]
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) insider James William Burns sold 1,707 shares of the firm’s stock in a transaction dated Friday, June 30th. The stock was sold at an average price of $28.36, for a total value of $48,410.52. Following the transaction, the insider now owns 30,285 shares in the company, valued at […]